Global Surgical Eye Care Market To Witness Remarkable Progress Through 2026

May 11, 2022

According to the report titled ‘Global Surgical Eye Care Market (2021 Edition) - Analysis by Product Type (Implantables, Consumables, Equipment), End User, By Region, By Country: Market Insight and Forecast with Impact of COVID-19 (2021-2026)’, available with MarketStudyReport, global surgical eye care market was valued at USD 10.26 billion in the year 2020 and is slated to witness remarkable progress during 2021-2026.

Surging prevalence of eye-related ailments such as refractive errors, cataract, diabetic retinopathy, and glaucoma, along with burgeoning senile population, and elevated demand for diagnostic tests are positively influencing the global surgical eye care market dynamics.

Request sample copy of this report:  

Moreover, incorporation of new & advanced technologies in emerging economies, with companies gunning for the introduction of sustainable eye implants, is amplifying the revenue scope of business sphere.

Interestingly, heightened recognition of the safety of procedure like laser technology and non-invasive cosmetic surgeries, among other developments is displaying promising avenues for businesses in this field.

Besides that, an uptick in people's per capita income, and prevention from severity of eye disorders has prompted frequent visits to hospitals for medical examination of vision, expediting the industry development.

Concerning end-user ambit, worldwide surgical eye care industry is classified into ambulatory surgical centers, hospitals, and others. Based on product type, the industry is categorized into equipment, consumables, and implantables.

In terms of geographical terrain, the market study spans across Europe, North America, Latin America, and Asia Pacific. Of these, North America market is poised to register a notable growth rate during the assessment timeframe.

The prominent companies expanding the competitive scope of global surgical eye care market include Alcon Inc., Glaukos Corporation, Hoya Corporation, NIDEK Co. Ltd., Johnson & Johnson, Bausch Health Companies Inc., The Cooper Companies Inc., Topcon Corporation, Carl Zeiss AG, and STAAR Surgical among others. 

It is worth noting that leading companies are constantly upskilling their products to enhance their customer base while making massive investments in the R & D of this domain. Citing an instance, Alcon, Inc. has primarily emphasized on eye innovations along with indulging in some strategic mergers & acquisition. In 2021, it received Food and Drug Administration (FDA) approval to introduce United States’ first trifocal lens called ‘Trifocal Intraocular Len (IOL)’, particularly designed for patients undergoing cataract surgery.

Chat with us